Nisa Investment Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.3K | Sell |
1,379
-18
| -1% | -$252 | ﹤0.01% | 1954 |
|
2025
Q1 | $21.8K | Buy |
1,397
+28
| +2% | +$438 | ﹤0.01% | 1835 |
|
2024
Q4 | $19.1K | Buy |
1,369
+96
| +8% | +$1.34K | ﹤0.01% | 1949 |
|
2024
Q3 | $11.8K | Buy |
1,273
+205
| +19% | +$1.91K | ﹤0.01% | 2064 |
|
2024
Q2 | $9.93K | Buy |
1,068
+943
| +754% | +$8.77K | ﹤0.01% | 2155 |
|
2024
Q1 | $1.24K | Buy |
+125
| New | +$1.24K | ﹤0.01% | 2324 |
|
2023
Q3 | – | Sell |
-46
| Closed | -$438 | – | 2775 |
|
2023
Q2 | $438 | Buy |
+46
| New | +$438 | ﹤0.01% | 2585 |
|
2023
Q1 | – | Sell |
-13,900
| Closed | -$206K | – | 2523 |
|
2022
Q4 | $206K | Sell |
13,900
-35
| -0.3% | -$519 | ﹤0.01% | 1364 |
|
2022
Q3 | $266K | Buy |
13,935
+35
| +0.3% | +$668 | ﹤0.01% | 1201 |
|
2022
Q2 | $296K | Hold |
13,900
| – | – | ﹤0.01% | 1202 |
|
2022
Q1 | $268K | Buy |
+13,900
| New | +$268K | ﹤0.01% | 1265 |
|